Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia

• Published in: BMC cancer 2019-06, Vol.19 (1), p.643-13, Article 643
• Main Authors: Petersen, Christian Hunnicke, Mahmood, Badar, Badsted, Christoffer, Dahlby, Tina, Rasmussen, Hanne Borger, Hansen, Mark Berner, Bindslev, Niels
• Format: Article
• Language: English
• Subjects: Akt; Carcinogenesis; Care and treatment; Colonoscopy; Colorectal cancer; Diagnosis; Enzyme-linked immunosorbent assay; Extracellular signal-regulated kinase (ERK); Gastrointestinal diseases; Gene expression; Genes; Genetic aspects; Genetic research; Medical research; Messenger RNA; Metabolites; Phosphatases; Prostaglandin E2; Prostaglandins; Prostaglandins E; Protein kinases; RNA; β-Catenin
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-019-5833-8

Investigations of colorectal carcinogenesis have mainly focused on examining neoplastic tissue. With our aim of identifying potentially cancer-predisposing molecular compositions, we chose a different approach by examining endoscopically normal appearing colonic mucosa of patients with and without colorectal neoplasia (CRN). Directed by this focus, we selected 18 genes that were previously found with altered expression in colorectal cancer affected mucosa. Biopsies of colonic mucosa were sampled from 27 patients referred for colonoscopy on suspicion of colorectal disease. Of these, 14 patients had present or previous CRN and the remaining 13 patients served as controls. Using qPCR and Western blot technique, we investigated mRNA and protein expressions. Expressions were investigated for selected kinases in the extracellular signal-regulated kinase/mitogen activated protein kinase (ERK/MAPK), the phosphoinositide 3-kinase/Akt, and the Wnt/β-catenin pathways as well as for selected phosphatases and several entities associated with prostaglandin E2 (PGE ) signaling. Colonic mucosal contents of PGE and PGE metabolites were determined by use of ELISA. We found up-regulation of ERK1, ERK2, Akt1, Akt2, PLA2G4A, prostanoid receptor EP3 and phosphatase scaffold subunit PPP2R1B mRNA expression in normal appearing colonic mucosa of CRN patients compared to controls. Present study supports that even normal appearing mucosa of CRN patients differs from that of non-CRN patients at a molecular level. Especially expression of ERK1 mRNA was increased (p = 0.007) in CRN group. ERK1 may therefore be considered a potential candidate gene as predictive biomarker for developing CRN. Further validation in larger cohorts are required to determine such predictive use in translational medicine and clinics.